Senior R&D Asset Transition & Integration Lead

POL - 6999 Takeda SCE

Warszawa

Hybrid

PLN 270,000 - 450,000

Full time

14 days+
Application generator

An application made for this job — a tailored resume and cover letter that speak straight to the posting.

Get past ATS filters

Job summary

Takeda in Warsaw, Poland, is seeking a Senior Manager to join the RATIO team and drive strategic R&D asset transitions across integrations, wind-downs, divestitures and externalizations. You will coordinate with Regulatory, Clinical, Pharmacovigilance, Legal and Finance, translating agreements into actionable plans and guiding delivery with senior leadership visibility.

The role blends science, operations and strategy, demanding rigorous data integrity, clear governance, and a collaborative

Qualifications

  • Bachelor's degree in a scientific field; advanced degree welcomed
  • 6+ years in pharma/biotech, esp. R&D strategy/operations or program management
  • Experience in global matrix environments
  • Experience working with external counterparties—partners, CROs, or vendors
  • Fluent English for global governance forums

Responsibilities

  • Lead or support R&D asset transitions with defined scope, sequencing, and timelines
  • Translate license agreements, transition plans, and post-term commitments into executable workplans
  • Coordinate delivery across Regulatory, Pharmacovigilance, Clinical Operations, Data & Tech, Legal, Finance
  • Manage study closeout, sample disposition, regulatory withdrawal, and data transfers
  • Support governance cadence and present to senior leadership forums
  • Execute transition activities such as data transfer, system migrations, and vendor transitions
  • Track post-term commitments and ensure obligations to partners and health authorities are met
  • Contribute to RATIO frameworks, playbooks and tools to improve efficiency

Education

Bachelor's degree in science

Job description

Takeda in Warsaw, Poland, is seeking a Senior Manager to join the RATIO team and drive strategic R&D asset transitions across integrations, wind-downs, divestitures and externalizations. You will coordinate with Regulatory, Clinical, Pharmacovigilance, Legal and Finance, translating agreements into actionable plans and guiding delivery with senior leadership visibility.

The role blends science, operations and strategy, demanding rigorous data integrity, clear governance, and a collaborative

Get your free, confidential resume review.

or drag and drop your file here.

Similar jobs

Similar jobs worth comparing

Strategic R&D Asset Transition Lead
Strategic R&D Asset Transition Lead

Takeda • Warszawa

Hybrid
PLN 260,000 - 460,000
Hybrid work model
Travel opportunities
Senior Manager, R&D Asset Transitions (Hybrid)
Senior Manager, R&D Asset Transitions (Hybrid)

Takeda Pharmaceutical Co. • Warszawa

Hybrid
PLN 320,000 - 480,000
Director, R&D Asset Transitions & Integration
Director, R&D Asset Transitions & Integration

POL - 6999 Takeda SCE • Warszawa

Hybrid
PLN 421,000 - 579,000
Director, Global R&D Asset Transitions & Integration
Director, Global R&D Asset Transitions & Integration

Takeda • Łódź

Hybrid
PLN 421,000 - 579,000
Hybrid work model
R&D Asset Transitions & Integration Director
R&D Asset Transitions & Integration Director

Takeda Pharmaceutical Co. • Warszawa

Hybrid
PLN 421,000 - 579,000
Senior Manager, R&D Asset Transition & Integration Office (RATIO)
Senior Manager, R&D Asset Transition & Integration Office (RATIO)

Takeda Pharmaceutical Co. • Warszawa

Hybrid
PLN 320,000 - 480,000
Senior Manager, R&D Asset Transition & Integration Office (RATIO)
Senior Manager, R&D Asset Transition & Integration Office (RATIO)

POL - 6999 Takeda SCE • Warszawa

Hybrid
PLN 270,000 - 450,000
Senior Manager, R&D Asset Transition & Integration Office (RATIO)
Senior Manager, R&D Asset Transition & Integration Office (RATIO)

Takeda • Warszawa

Hybrid
PLN 260,000 - 460,000
Hybrid work model
Travel opportunities
Director, R&D Asset Transition & Integration Office (RATIO)
Director, R&D Asset Transition & Integration Office (RATIO)

Takeda Pharmaceutical Co. • Warszawa

Hybrid
PLN 421,000 - 579,000
Director, R&D Asset Transition & Integration Office (RATIO)
Director, R&D Asset Transition & Integration Office (RATIO)

POL - 6999 Takeda SCE • Warszawa

Hybrid
PLN 421,000 - 579,000